Nattapol Pongsamai

Mr. Nattapol Pongsamai


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2025 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
Rayudika Aprilia Patindra PurbaRayudika Aprilia Patindra Purba
Rayudika Aprilia Patindra Purba
PLPhanthipha Laosam
Phanthipha Laosam
NPNattapol Pongsamai
Nattapol Pongsamai
Papungkorn SangsawadPapungkorn Sangsawad
Papungkorn Sangsawad
This investigation presents a rigorous comparative evaluation of methanolic and hexanoic extracts from Takhrai (Cymbopogon citratus) leaves against commercial antioxidants for mitigating oxidative stress in heat-stressed ruminants. Phytochemical profiling revealed significantly higher concentrations of bioactive compounds in methanolic extracts, particularly ascorbic acid (2.12 ± 0.08 mg/g), sinapic acid (0.71 ± 0.03 mg/g), and apigenin (0.38 ± 0.02 mg/g). Methanolic extracts demonstrated exceptional antioxidant activities (DPPH IC50 = 36.62 ± 0.65 μg/mL), superior erythrocyte protection (hemoglobin oxidation IC50 = 12.06 ± 0.29 μg/mL), and robust Nrf2 pathway activation (HO-1 induction = 3.42 ± 0.17-fold). Metabolomic analyses revealed preservation of glutathione metabolism and attenuation of lipid peroxidation product accumulation. Immunomodulatory assessment demonstrated significant reduction of pro-inflammatory cytokines (TNF-α reduced by 54.3 ± 4.8%) and enhancement of anti-inflammatory mediators following LPS challenge. While storage stability presented limitations at ambient conditions (52.4 ± 3.7% activity retention after 6 months), refrigeration substantially improved preservation (92.3 ± 2.8%). Comprehensive effectiveness ranking across twelve parameters positioned methanolic extracts (mean score 1.7) comparable to vitamin E (1.6) and superior to other interventions. Collectively, these findings establish methanolic Takhrai extracts as promising sustainable alternatives to commercial antioxidants, with particular relevance for ruminant production in tropical regions

19 September 2026 in Food Science of Animal Resources
Verified
Journal Article
Open access
PDF file
PLPhanthipha Laosam
Phanthipha Laosam
FZFuping Zhang
Fuping Zhang
MRMahmoud Rouabhia
Mahmoud Rouabhia
SSSaranya Suwanangul
Saranya Suwanangul
JPJukkrapong Pinyo
Jukkrapong Pinyo
Papungkorn SangsawadPapungkorn Sangsawad
Papungkorn Sangsawad
This is a comprehensive review focusing on the utilization of slaughter blood proteins as sources of bioactive peptides for functional food applications. Despite significant advances in bioactive peptide research, critical knowledge gaps remain regarding species-specific variations in peptide bioactivity and the complex interplay between processing methods and functional properties. Enzymatic hydrolysis using various proteases generates peptides with diverse bioactivities, including antioxidant, anti-inflammatory, ACE-inhibitory, and DPP-IV inhibitory effects. This review uniquely integrates proteolytic mechanisms with in-depth molecular characterization across multiple animal sources, addressing the previously fragmented understanding of structure-function relationships. Notably, gastrointestinal stability is significantly enhanced by proline residues and hydrophobic amino acids, offering a novel structural insight for predicting peptide bioavailability. Hemoglobin decolorization methods enable broader food industry applications. Recent innovations in processing technologies and delivery systems position blood-derived peptides as valuable functional ingredients for sustainable food systems.

18 May 2026 in Foods
Verified
Journal Article
Open access
PDF file
PLPhanthipha Laosam
Phanthipha Laosam
FZFuping Zhang
Fuping Zhang
PLPichitpon Luasiri
Pichitpon Luasiri
SSSaranya Suwanangul
Saranya Suwanangul
NPNattapol Pongsamai
Nattapol Pongsamai
Papungkorn SangsawadPapungkorn Sangsawad
Papungkorn Sangsawad
Goat blood, a major slaughterhouse by-product, was systematically valorized into dual-function bioactive peptides through an optimized four-step process. Four blood preparations—whole blood (HB), anticoagulant-treated blood (HBS), red blood corpuscles (BC), and plasma (PM)—were subjected to heat pretreatment (90 °C, 15 min) and enzymatic hydrolysis. Neutrase hydrolysis of heat-pretreated whole blood at 8% substrate concentration for 4 h (HBN-8) yielded optimal protein recovery (44.38%) with dual ACE (88.24%) and DPP-IV (81.13%) inhibition. Ultrafiltration enriched bioactive peptides in the ≤3 kDa fraction (DPP-IV: 87.8%; ACE: 65.5%). LC-MS/MS de novo sequencing identified 14 novel peptide sequences (4–9 amino acids), with the most potent SEC fraction showing IC50 values of 0.89 and 0.45 mg Leu eq./mL for DPP-IV and ACE inhibition, respectively. Critically, simulated gastrointestinal digestion enhanced rather than diminished bioactivity, with ACE inhibition increasing progressively to 60.91% at the intestinal phase, supported by predicted generation of bioactive fragments from parent sequences. Caco-2 assays confirmed peptide safety (100–1000 µg/mL) and demonstrated 10.47% transepithelial transport with retained dual inhibitory activities. This study establishes goat blood as a sustainable source of orally bioavailable, GI-stable peptides for the development of functional foods targeting hypertension and type 2 diabetes.